Fadi G. Haddad

Pediatric Gastroenterology
5201 Deer Valley Rd Ste 1E
Antioch, CA 94531

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 117 publications

Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis.

Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis.

Journal: Cancers
Published: June 07, 2026

Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoring.

Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoring.

Journal: Leukemia & lymphoma
Published: June 01, 2026

Results of Third-Line Therapy in Philadelphia Chromosome-Positive Adult Acute Lymphoblastic Leukemia.

Results of Third-Line Therapy in Philadelphia Chromosome-Positive Adult Acute Lymphoblastic Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia
Published: May 27, 2026

Review of Bleeding as Initial Presentation in Patients with Chronic Myeloid Leukemia.

Review of Bleeding as Initial Presentation in Patients with Chronic Myeloid Leukemia.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: April 27, 2026

Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage.

Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage.

Journal: Leukemia
Published: March 31, 2026

Tyrosine kinase inhibitors, chronic myeloid leukemia, and pregnancy: pharmacotherapeutic challenges and recommendations.

Tyrosine kinase inhibitors, chronic myeloid leukemia, and pregnancy: pharmacotherapeutic challenges and recommendations.

Journal: Expert opinion on pharmacotherapy
Published: March 24, 2026

Results of second-line therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

Results of second-line therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

Journal: Cancer
Published: March 19, 2026

Chronic myeloid leukemia: incorporation of recent advances into current treatment algorithms.

Chronic myeloid leukemia: incorporation of recent advances into current treatment algorithms.

Journal: Blood cancer journal
Published: February 18, 2026

Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia.

Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia.

Journal: American journal of hematology
Published: February 09, 2026

Case series: rhabdomyolysis in patients taking isocitrate dehydrogenase inhibitors for myelodysplastic syndrome and relapsed/refractory acute myeloid leukemia.

Case series: rhabdomyolysis in patients taking isocitrate dehydrogenase inhibitors for myelodysplastic syndrome and relapsed/refractory acute myeloid leukemia.

Journal: Leukemia & lymphoma
Published: February 02, 2026

Predictors of Relapse and Post-Relapse Outcomes After Frontline Blinatumomab in Philadelphia Chromosome-Negative B-ALL.

Predictors of Relapse and Post-Relapse Outcomes After Frontline Blinatumomab in Philadelphia Chromosome-Negative B-ALL.

Journal: American journal of hematology
Published: February 01, 2026

Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

Journal: Cancer
Published: January 28, 2026
Showing 1-12 of 117

Last Updated: 09/26/2026